Vol. 2, Issue 1, / January-March 2001
(Original Article, pages 63-67)

Tahereh Madani Corresponding Author
- Royan Research Center, Endocrinology & Infertility Department, Tehran, Iran
Mahnaz Ashrafi
1- Royan Research Center, Endocrinology & Infertility Department, Tehran, Iran
2- Department of Obstetrics and Gynecology, Shahid Akbarabadi Hospital, Faculty of Medicine, Iran university of Medical Sciences, Tehran, Iran
Mahnaz Yavangy
- Hamedan Medical Sciences University, Hamadan, Iran

Received: 9/27/2000 Accepted: 2/13/2001 - Publisher : Avicenna Research Institute

Related Articles


Other Format



Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulation in women during reproduction years. In this syndrome the first choice for ovulation induction is clomiphene citrate. Approximately 15-25% of patients have been shown to be resistant to even high levels clomiphene and fail to ovulate. To assess the relationship between ovarian unresponsiveness to clomiphene and some clinical and paraclinical factors in PCOS, a prospective, randomized clinical trial was performed on patients referring to the Royan Institute between May 1998 to May 2000. Fifty three PCOS patients with at least 5 successive years of infertility and an age range of 25-35 years were randomly selected. All patients suffered from oligomenorrhea, hirsutism and in all patients baseline concentrations of FSH, LH, testosterone, FBS, fasting insulin, androstandione, 17--hydroxy progesterone and DHEAs were determined. In all patients the body mass index (BMI), ovarian volume and the number of follicles in each ovary were measured. After transvaginal sonography on 3rd day of menstrual cycle, the patients were treated with clomiphene citrate in 2 cycles. In the first cycle 100 mg/day clomiphene citrate was administered from day 5 to day 9 of the cyle and if no response, the second cycle included 150 mg/day clomiphene citrate and the rate of ovulation was studied. With respect to ovulation the patients were divided in 2 groups, group 1 with ovulation and group 2 without ovulation Usingt student test, the two groups were statistically compared. The ovarian volumes were 8.64.3ml (MeanSD) and 8.743.7ml in groups 1 and 2, respectively.The BMI in the 2 groups were 28.03.8 and 29.724.36 (meanSD), respectively. No siginficant difference were observed between the 2 groups in these cases. However, 72.4% of patients in group 1 and 45.8% in group 2 had <10 follicles in each ovary (p<0.05). There results suggest no correlation between ovarian volume or BMI and response to clomiphene. However, our findings are highly suggestive of a correlation between number of primary follicles in each ovary and responsiveness to clomiphene, and thus measurement of primary follicle number in ovaries may be a predictive factor for clomiphene responsiveness.

Keywords: Ovarian volume, BMI, Clomiphene citrate, Polycystic ovary syndrome

To cite this article:


  1. Amma A., Kyai-Mensah., Lintan S. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod. 1998; 13 (6):1437-41
  2. Carmina E., Gonzalez F., Vidali A., et al. The contribution of estrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome.Hum Reprod. 1999; 14:307-11
  3. Fulghesu A.M., Cucinelli F., Pavone V., et al. Changes in luteinizing hormoe and insulin secretion in polycystic ovarian syndrome. Hum. Reprod. 1999; 14:611-7
  4. David V., Polson M.R. Induciton of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and nonresponders. Fertil Steril. 1989;51(1):30-4
  5. Sundus A., watkin K. Ovarian stromal echogenicity in women with clomiphene citrate sensetive and clomiphene citrate resistant ploycystic ovary syndorme. Fertil Steril.1999;71(5): 952-4
  6. Brace R., Carr B.R. Black Well R.E.Text book of Reproductive Medicine, Second Edition, Appleton Lange, USA, pp:571-2
  7. Lena H., Kim,. Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility? Fertil Steril. 2000;73(6):1097-9
  8. Takahashi K. Transvaginal ultrasonic assessment of the response to clomiphene citrate in polycystic ovarian syndrome. Fertil Steril.1994; 62:48-53
  9. Amir Lass., Brinsden P. The role of ovarian volume in reproductive medicin. Hum Reprod Update. 1999; 5(3):256-86
  10. Lobo RA. Clinical and laboratory predictors of clomiphene response. Fertil Steril. 1982; 37(2):168-74
  11. Acien P. Insulin, androgens and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders Fertil Steril. 1999; 7(1):32-9
  12. Pellicer A. Evaluation of the ovarian severe in young low responders with normal basal levels of follicle–stimulating hormone using three – demensional ultrasonography. Fertil Steril. 1998; 70(4):671-5


Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.